Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Formulating Isotonic Nasal Sprays

Posted on By

SOP for Formulating Isotonic Nasal Sprays



Standard Operating Procedure for Formulating Isotonic Nasal Sprays

1) Purpose

The purpose of this SOP is to provide detailed instructions for formulating isotonic nasal sprays to ensure optimal osmolality and patient safety.

2) Scope

This SOP applies to all personnel involved in the formulation of isotonic nasal sprays at [Company Name].

3) Responsibilities

  • Operators: Responsible for preparing isotonic solutions according to formulation guidelines.
  • QA: Verifies osmolality and ensures compliance with formulation standards.

4) Procedure

4.1 Preparation of Isotonic Solution

4.1.1 Equipment Setup

  • Ensure all measuring and mixing equipment is clean and calibrated.
  • Prepare an osmolality meter to measure the isotonicity of the formulation.
See also  SOP for Solubility Enhancement Techniques in Nasal Formulations

4.1.2 Mixing the Solution

  • Weigh the correct amount of sodium chloride or other tonicity agents as specified in the formulation.
  • Dissolve the agents in the required amount of purified water using aseptic techniques.

4.2 Osmolality Testing

4.2.1 Measuring Osmolality

  • Use a calibrated osmolality meter to test the solution’s osmolality.
  • If the value is within the target range (270-330 mOsm/kg), proceed to the next steps. If not, adjust the formulation by adding purified water or additional tonicity agents.

4.2.2 Documentation

  • Record the osmolality readings in the osmolality testing log, and verify with the QA
department.

4.3 Final Filtration and Packaging

4.3.1 Filtration

  • Filter the isotonic nasal spray solution through a 0.22-micron filter before packaging to ensure sterility.

4.3.2 Packaging

  • Transfer the filtered solution into sterilized nasal spray containers using aseptic techniques.
  • Label the containers with batch number, formulation name, and production date.

5) Abbreviations, if any

  • QA: Quality Assurance

6) Documents, if any

  • Osmolality Testing Log
  • Batch Manufacturing Record (BMR)

7) References, if any

  • USP 39 – Tonicity of Solutions

8) SOP Version

Version 1.0

Annexure

Osmolality Testing Log Template

Date Formulation Osmolality (mOsm/kg) Operator Initials QA Approval
DD/MM/YYYY Formulation Name Value Operator Name QA Name
           
See also  SOP for Preparing Nasal Sprays for Elderly Patients
Nasal Spray Formulations Tags:Cleaning SOP for nasal spray equipment, Environmental control in nasal spray production, Equipment maintenance for nasal sprays, Formulating isotonic nasal sprays, Microbial stability in nasal formulations, Mixing SOP for nasal formulations, Nasal spray API formulation, Nasal spray batch manufacturing SOP, Nasal spray filling machine operation, Nasal spray formulation process, Nasal spray GMP guidelines, Nasal spray homogenization techniques, Nasal spray manufacturing process, Nasal spray packaging SOP, Nasal spray preservative-free formulation, Nasal spray production SOP, Nasal spray stability studies, Nasal spray sterilization process, Nasal spray viscosity monitoring, Particle size control in nasal sprays, pH adjustment in nasal formulations, Quality control in nasal spray production, Solvent selection for nasal sprays, SOP for nasal spray manufacturing, SOP for nasal spray testing

Post navigation

Previous Post: SOP for pH Adjustment and Buffer Preparation for Nasal Formulations
Next Post: SOP for Preparation and Sterilization of API and Excipients

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version